Organovo is a pioneer in the development of human primary cell 3-D bioprinted tissues. The primary effort to develop a human therapeutic liver tissue candidate was halted and the company restructured to focus on utilizing its tissues for disease modeling and drug discovery, with the therapeutic liver tissue development on hold pending additional advances.